|
|
mesonephric duct formation
|
GO:0072181 |
2 |
0.118
|
|
|
|
microtubule cytoskeleton organization
|
GO:0000226 |
157 |
0.108
|
|
|
|
inorganic ion transmembrane transport
|
GO:0098660 |
234 |
0.097
|
|
|
|
microtubule based process
|
GO:0007017 |
236 |
0.092
|
|
|
|
transmembrane transport
|
GO:0055085 |
412 |
0.087
|
|
|
|
ubiquitin dependent protein catabolic process
|
GO:0006511 |
129 |
0.084
|
|
|
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.079
|
|
|
|
inorganic cation transmembrane transport
|
GO:0098662 |
207 |
0.075
|
|
|
|
cellular macromolecule catabolic process
|
GO:0044265 |
206 |
0.062
|
|
|
|
male gamete generation
|
GO:0048232 |
285 |
0.061
|
|
|
|
lung induction
|
GO:0060492 |
3 |
0.060
|
|
|
|
regulation of body fluid levels
|
GO:0050878 |
162 |
0.060
|
|
|
|
modification dependent macromolecule catabolic process
|
GO:0043632 |
133 |
0.058
|
|
|
|
reactive oxygen species metabolic process
|
GO:0072593 |
84 |
0.056
|
|
|
|
negative regulation of synapse assembly
|
GO:0051964 |
3 |
0.055
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.055
|
|
|
|
germ cell development
|
GO:0007281 |
185 |
0.053
|
|
|
|
kidney development
|
GO:0001822 |
213 |
0.052
|
|
|
|
myoblast differentiation involved in skeletal muscle regeneration
|
GO:0014835 |
3 |
0.051
|
|
|
|
protein modification by small protein conjugation or removal
|
GO:0070647 |
207 |
0.050
|
|
|
|
negative regulation of phosphorylation
|
GO:0042326 |
166 |
0.049
|
|
|
|
rho protein signal transduction
|
GO:0007266 |
32 |
0.049
|
|
|
|
peptidyl serine modification
|
GO:0018209 |
83 |
0.049
|
|
|
|
interleukin 8 secretion
|
GO:0072606 |
3 |
0.048
|
|
|
|
response to molecule of bacterial origin
|
GO:0002237 |
143 |
0.045
|
|
|
|
regulation of canonical wnt signaling pathway involved in controlling type b pancreatic cell proliferation
|
GO:2000079 |
1 |
0.045
|
|
|
|
modification dependent protein catabolic process
|
GO:0019941 |
133 |
0.044
|
|
|
|
inner medullary collecting duct development
|
GO:0072061 |
2 |
0.044
|
|
|
|
negative regulation of intracellular signal transduction
|
GO:1902532 |
167 |
0.043
|
|
|
|
regulation of interleukin 8 secretion
|
GO:2000482 |
2 |
0.043
|
|
|
|
sulfur compound metabolic process
|
GO:0006790 |
100 |
0.043
|
|
|
|
protein ubiquitination
|
GO:0016567 |
171 |
0.041
|
|
|
|
actin cytoskeleton organization
|
GO:0030036 |
220 |
0.041
|
|
|
|
organonitrogen compound catabolic process
|
GO:1901565 |
264 |
0.041
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
263 |
0.041
|
|
|
|
cellular response to biotic stimulus
|
GO:0071216 |
92 |
0.040
|
|
|
|
cellular protein catabolic process
|
GO:0044257 |
155 |
0.040
|
|
|
|
negative regulation of protein modification process
|
GO:0031400 |
163 |
0.040
|
|
|
|
nucleotide catabolic process
|
GO:0009166 |
217 |
0.039
|
|
|
|
spermatogenesis
|
GO:0007283 |
284 |
0.039
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.039
|
|
|
|
positive regulation of rna polymerase ii transcriptional preinitiation complex assembly
|
GO:0045899 |
2 |
0.039
|
|
|
|
positive regulation of anagen
|
GO:0051885 |
1 |
0.038
|
|
|
|
nephric duct formation
|
GO:0072179 |
4 |
0.037
|
|
|
|
cell cell junction organization
|
GO:0045216 |
72 |
0.037
|
|
|
|
ion transmembrane transport
|
GO:0034220 |
361 |
0.036
|
|
|
|
leukocyte migration
|
GO:0050900 |
124 |
0.036
|
|
|
|
endomembrane system organization
|
GO:0010256 |
147 |
0.036
|
|
|
|
regionalization
|
GO:0003002 |
337 |
0.035
|
|
|
|
regulation of mapk cascade
|
GO:0043408 |
248 |
0.034
|
|
|
|
positive regulation of interleukin 8 production
|
GO:0032757 |
2 |
0.034
|
|
|
|
cation transport
|
GO:0006812 |
399 |
0.034
|
|
|
|
g protein coupled receptor signaling pathway
|
GO:0007186 |
243 |
0.034
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.034
|
|
|
|
midbrain hindbrain boundary maturation
|
GO:0021732 |
1 |
0.033
|
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.033
|
|
|
|
calcium independent cell cell adhesion via plasma membrane cell adhesion molecules
|
GO:0016338 |
4 |
0.032
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.032
|
|
|
|
interleukin 8 production
|
GO:0032637 |
4 |
0.032
|
|
|
|
outer medullary collecting duct development
|
GO:0072060 |
1 |
0.031
|
|
|
|
anatomical structure maturation
|
GO:0071695 |
49 |
0.031
|
|
|
|
establishment of organelle localization
|
GO:0051656 |
122 |
0.031
|
|
|
|
protein modification by small protein conjugation
|
GO:0032446 |
187 |
0.030
|
|
|
|
mitotic cell cycle
|
GO:0000278 |
195 |
0.030
|
|
|
|
central nervous system morphogenesis
|
GO:0021551 |
2 |
0.030
|
|
|
|
spemann organizer formation at the anterior end of the primitive streak
|
GO:0060064 |
1 |
0.030
|
|
|
|
organelle localization
|
GO:0051640 |
179 |
0.029
|
|
|
|
negative regulation of phosphate metabolic process
|
GO:0045936 |
184 |
0.029
|
|
|
|
renal outer medulla development
|
GO:0072054 |
2 |
0.029
|
|
|
|
regulation of testosterone biosynthetic process
|
GO:2000224 |
2 |
0.029
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.028
|
|
|
|
kidney rudiment formation
|
GO:0072003 |
3 |
0.028
|
|
|
|
cell junction organization
|
GO:0034330 |
77 |
0.028
|
|
|
|
ubiquitin dependent smad protein catabolic process
|
GO:0030579 |
2 |
0.028
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.028
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.028
|
|
|
|
regulation of transforming growth factor beta2 production
|
GO:0032909 |
2 |
0.028
|
|
|
|
regulation of reactive oxygen species metabolic process
|
GO:2000377 |
40 |
0.028
|
|
|
|
interleukin 6 production
|
GO:0032635 |
58 |
0.027
|
|
|
|
cell cell junction assembly
|
GO:0007043 |
27 |
0.027
|
|
|
|
transforming growth factor beta2 production
|
GO:0032906 |
2 |
0.027
|
|
|
|
multicellular organismal signaling
|
GO:0035637 |
91 |
0.027
|
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
217 |
0.027
|
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.027
|
|
|
|
response to starvation
|
GO:0042594 |
65 |
0.027
|
|
|
|
regulation of anagen
|
GO:0051884 |
1 |
0.027
|
|
|
|
negative regulation of meiotic cell cycle phase transition
|
GO:1901994 |
3 |
0.027
|
|
|
|
response to extracellular stimulus
|
GO:0009991 |
127 |
0.027
|
|
|
|
lipid transport
|
GO:0006869 |
98 |
0.027
|
|
|
|
mapk cascade
|
GO:0000165 |
281 |
0.026
|
|
|
|
paraxial mesodermal cell differentiation
|
GO:0048342 |
2 |
0.026
|
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
194 |
0.026
|
|
|
|
rna polymerase ii transcriptional preinitiation complex assembly
|
GO:0051123 |
3 |
0.026
|
|
|
|
neuronal action potential
|
GO:0019228 |
54 |
0.026
|
|
|
|
hindbrain formation
|
GO:0021576 |
1 |
0.026
|
|
|
|
oxygen homeostasis
|
GO:0032364 |
2 |
0.026
|
|
|
|
sodium ion transport
|
GO:0006814 |
73 |
0.025
|
|
|
|
mesonephric duct morphogenesis
|
GO:0072180 |
4 |
0.025
|
|
|
|
response to oxidative stress
|
GO:0006979 |
123 |
0.025
|
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.025
|
|
|
|
cellular homeostasis
|
GO:0019725 |
240 |
0.025
|
|
|
|
cation transmembrane transport
|
GO:0098655 |
266 |
0.025
|
|
|
|
meiotic cell cycle process
|
GO:1903046 |
77 |
0.025
|
|
|
|
regulation of vesicle mediated transport
|
GO:0060627 |
139 |
0.025
|
|
|
|
regulation of cell cycle process
|
GO:0010564 |
160 |
0.025
|
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.024
|
|
|
|
paramesonephric duct development
|
GO:0061205 |
3 |
0.024
|
|
|
|
metanephric loop of henle development
|
GO:0072236 |
4 |
0.024
|
|
|
|
meiotic cell cycle
|
GO:0051321 |
122 |
0.024
|
|
|
|
cellular response to molecule of bacterial origin
|
GO:0071219 |
83 |
0.024
|
|
|
|
positive regulation of transforming growth factor beta2 production
|
GO:0032915 |
2 |
0.024
|
|
|
|
positive regulation of secretion by cell
|
GO:1903532 |
114 |
0.024
|
|
|
|
inflammatory response
|
GO:0006954 |
244 |
0.024
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.024
|
|
|
|
regulation of microtubule based process
|
GO:0032886 |
52 |
0.024
|
|
|
|
central nervous system vasculogenesis
|
GO:0022009 |
3 |
0.024
|
|
|
|
negative regulation of cell cycle
|
GO:0045786 |
123 |
0.024
|
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
232 |
0.024
|
|
|
|
regulation of membrane potential
|
GO:0042391 |
192 |
0.023
|
|
|
|
stress activated mapk cascade
|
GO:0051403 |
80 |
0.023
|
|
|
|
skin development
|
GO:0043588 |
220 |
0.023
|
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.023
|
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.023
|
|
|
|
cell cell adhesion via plasma membrane adhesion molecules
|
GO:0098742 |
40 |
0.023
|
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.023
|
|
|
|
cell division
|
GO:0051301 |
120 |
0.023
|
|
|
|
skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration
|
GO:0014834 |
3 |
0.023
|
|
|
|
body fluid secretion
|
GO:0007589 |
53 |
0.022
|
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
197 |
0.022
|
|
|
|
sensory organ morphogenesis
|
GO:0090596 |
242 |
0.022
|
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.022
|
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.021
|
|
|
|
type b pancreatic cell proliferation
|
GO:0044342 |
10 |
0.021
|
|
|
|
proton transport
|
GO:0015992 |
35 |
0.021
|
|
|
|
digestive tract morphogenesis
|
GO:0048546 |
147 |
0.021
|
|
|
|
negative regulation of testosterone biosynthetic process
|
GO:2000225 |
1 |
0.021
|
|
|
|
exocytosis
|
GO:0006887 |
121 |
0.021
|
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
208 |
0.021
|
|
|
|
cell junction assembly
|
GO:0034329 |
52 |
0.021
|
|
|
|
regulation of map kinase activity
|
GO:0043405 |
120 |
0.021
|
|
|
|
glycosyl compound metabolic process
|
GO:1901657 |
246 |
0.021
|
|
|
|
axon ensheathment
|
GO:0008366 |
76 |
0.021
|
|
|
|
positive regulation of cell death
|
GO:0010942 |
224 |
0.021
|
|
|
|
positive regulation of canonical wnt signaling pathway involved in controlling type b pancreatic cell proliferation
|
GO:2000081 |
1 |
0.021
|
|
|
|
negative regulation of fibroblast growth factor production
|
GO:0090272 |
2 |
0.020
|
|
|
|
regulation of cell motility
|
GO:2000145 |
236 |
0.020
|
|
|
|
regulation of ketone biosynthetic process
|
GO:0010566 |
2 |
0.020
|
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
206 |
0.020
|
|
|
|
positive regulation of interleukin 8 secretion
|
GO:2000484 |
1 |
0.020
|
|
|
|
purine nucleoside triphosphate catabolic process
|
GO:0009146 |
203 |
0.020
|
|
|
|
canonical wnt signaling pathway involved in regulation of type b pancreatic cell proliferation
|
GO:0044343 |
1 |
0.020
|
|
|
|
fibroblast growth factor production
|
GO:0090269 |
4 |
0.020
|
|
|
|
digestive tract development
|
GO:0048565 |
190 |
0.020
|
|
|
|
regulation of actin cytoskeleton organization
|
GO:0032956 |
84 |
0.020
|
|
|
|
morphogenesis of embryonic epithelium
|
GO:0016331 |
159 |
0.020
|
|
|
|
ribonucleoside metabolic process
|
GO:0009119 |
245 |
0.020
|
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.020
|
|
|
|
establishment of organ orientation
|
GO:0048561 |
1 |
0.020
|
|
|
|
lateral sprouting involved in mammary gland duct morphogenesis
|
GO:0060599 |
2 |
0.020
|
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.019
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.019
|
|
|
|
actin filament organization
|
GO:0007015 |
113 |
0.019
|
|
|
|
wnt signaling pathway calcium modulating pathway
|
GO:0007223 |
2 |
0.019
|
|
|
|
spemann organizer formation
|
GO:0060061 |
2 |
0.019
|
|
|
|
regulation of asymmetric cell division
|
GO:0009786 |
4 |
0.019
|
|
|
|
osteoclast differentiation
|
GO:0030316 |
62 |
0.019
|
|
|
|
positive regulation of t cell anergy
|
GO:0002669 |
4 |
0.019
|
|
|
|
dna templated transcriptional preinitiation complex assembly
|
GO:0070897 |
4 |
0.019
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.019
|
|
|
|
endocytosis
|
GO:0006897 |
168 |
0.019
|
|
|
|
negative regulation of mapk cascade
|
GO:0043409 |
65 |
0.019
|
|
|
|
epithelial cell proliferation
|
GO:0050673 |
174 |
0.019
|
|
|
|
ras protein signal transduction
|
GO:0007265 |
77 |
0.019
|
|
|
|
peptidyl tyrosine modification
|
GO:0018212 |
145 |
0.019
|
|
|
|
detection of molecule of bacterial origin
|
GO:0032490 |
2 |
0.019
|
|
|
|
fat cell differentiation
|
GO:0045444 |
160 |
0.019
|
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
241 |
0.019
|
|
|
|
epithelial cell migration
|
GO:0010631 |
63 |
0.018
|
|
|
|
negative regulation of protein phosphorylation
|
GO:0001933 |
126 |
0.018
|
|
|
|
glycosyl compound catabolic process
|
GO:1901658 |
206 |
0.018
|
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
323 |
0.018
|
|
|
|
positive regulation of organelle organization
|
GO:0010638 |
128 |
0.018
|
|
|
|
negative regulation of cellular amino acid metabolic process
|
GO:0045763 |
0 |
0.018
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.018
|
|
|
|
t cell activation
|
GO:0042110 |
289 |
0.018
|
|
|
|
negative regulation of kinase activity
|
GO:0033673 |
81 |
0.018
|
|
|
|
negative regulation of alcohol biosynthetic process
|
GO:1902931 |
4 |
0.018
|
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
222 |
0.018
|
|
|
|
negative regulation of cellular amine metabolic process
|
GO:0033239 |
1 |
0.018
|
|
|
|
ensheathment of neurons
|
GO:0007272 |
76 |
0.018
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.018
|
|
|
|
trabecula morphogenesis
|
GO:0061383 |
40 |
0.018
|
|
|
|
oviduct development
|
GO:0060066 |
3 |
0.018
|
|
|
|
regulation of fibroblast growth factor production
|
GO:0090270 |
4 |
0.018
|
|
|
|
cell cell adhesion
|
GO:0098609 |
41 |
0.018
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.017
|
|
|
|
regulation of ph
|
GO:0006885 |
26 |
0.017
|
|
|
|
positive regulation of cell cycle
|
GO:0045787 |
92 |
0.017
|
|
|
|
sphingolipid biosynthetic process
|
GO:0030148 |
26 |
0.017
|
|
|
|
cell cycle switching
|
GO:0060184 |
1 |
0.017
|
|
|
|
positive regulation of cellular catabolic process
|
GO:0031331 |
148 |
0.017
|
|
|
|
regulation of intrinsic apoptotic signaling pathway
|
GO:2001242 |
61 |
0.017
|
|
|
|
tertiary branching involved in mammary gland duct morphogenesis
|
GO:0060748 |
3 |
0.017
|
|
|
|
response to lipopolysaccharide
|
GO:0032496 |
128 |
0.017
|
|
|
|
regulation of protein serine threonine kinase activity
|
GO:0071900 |
157 |
0.017
|
|
|
|
regulation of interleukin 8 production
|
GO:0032677 |
3 |
0.017
|
|
|
|
regulation of interleukin 6 production
|
GO:0032675 |
55 |
0.017
|
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.017
|
|
|
|
renal tubule morphogenesis
|
GO:0061333 |
72 |
0.017
|
|
|
|
nucleoside catabolic process
|
GO:0009164 |
206 |
0.017
|
|
|
|
cellular protein complex assembly
|
GO:0043623 |
116 |
0.016
|
|
|
|
protein catabolic process
|
GO:0030163 |
221 |
0.016
|
|
|
|
organelle fission
|
GO:0048285 |
170 |
0.016
|
|
|
|
regulation of stress activated mapk cascade
|
GO:0032872 |
69 |
0.016
|
|
|
|
action potential
|
GO:0001508 |
78 |
0.016
|
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
280 |
0.016
|
|
|
|
positive regulation of protein modification by small protein conjugation or removal
|
GO:1903322 |
30 |
0.016
|
|
|
|
establishment or maintenance of polarity of embryonic epithelium
|
GO:0016332 |
1 |
0.016
|
|
|
|
plasma membrane organization
|
GO:0007009 |
90 |
0.016
|
|
|
|
epithelial cell development
|
GO:0002064 |
159 |
0.016
|
|
|
|
protein maturation
|
GO:0051604 |
176 |
0.016
|
|
|
|
regulation of cell cell adhesion mediated by cadherin
|
GO:2000047 |
2 |
0.016
|
|
|
|
peptidyl threonine phosphorylation
|
GO:0018107 |
31 |
0.016
|
|
|
|
hypophysis morphogenesis
|
GO:0048850 |
3 |
0.016
|
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
199 |
0.016
|
|
|
|
nucleoside triphosphate catabolic process
|
GO:0009143 |
205 |
0.016
|
|
|
|
nucleoside metabolic process
|
GO:0009116 |
246 |
0.016
|
|
|
|
response to fructose
|
GO:0009750 |
2 |
0.016
|
|
|
|
negative regulation of transferase activity
|
GO:0051348 |
85 |
0.016
|
|
|
|
lung field specification
|
GO:0060424 |
3 |
0.016
|
|
|
|
digestion
|
GO:0007586 |
40 |
0.016
|
|
|
|
maintenance of cell number
|
GO:0098727 |
3 |
0.016
|
|
|
|
negative regulation of cell development
|
GO:0010721 |
169 |
0.016
|
|
|
|
mitotic cell cycle process
|
GO:1903047 |
159 |
0.016
|
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
230 |
0.016
|
|
|
|
positive regulation of meiotic cell cycle
|
GO:0051446 |
15 |
0.015
|
|
|
|
paraxial mesodermal cell fate commitment
|
GO:0048343 |
2 |
0.015
|
|
|
|
hair cycle phase
|
GO:0044851 |
16 |
0.015
|
|
|
|
negative regulation of cell morphogenesis involved in differentiation
|
GO:0010771 |
48 |
0.015
|
|
|
|
regulation of ras protein signal transduction
|
GO:0046578 |
114 |
0.015
|
|
|
|
stress activated protein kinase signaling cascade
|
GO:0031098 |
81 |
0.015
|
|
|
|
immune response activating signal transduction
|
GO:0002757 |
116 |
0.015
|
|
|
|
positive regulation of neuron differentiation
|
GO:0045666 |
141 |
0.015
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
281 |
0.015
|
|
|
|
proteasome mediated ubiquitin dependent protein catabolic process
|
GO:0043161 |
88 |
0.015
|
|
|
|
regulation of cell cycle phase transition
|
GO:1901987 |
77 |
0.015
|
|
|
|
regulation of protein tyrosine kinase activity
|
GO:0061097 |
17 |
0.015
|
|
|
|
regulation of secretion
|
GO:0051046 |
274 |
0.015
|
|
|
|
regulation of transposition
|
GO:0010528 |
2 |
0.015
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.015
|
|
|
|
positive regulation of cell cycle process
|
GO:0090068 |
61 |
0.015
|
|
|
|
regulation of cardioblast differentiation
|
GO:0051890 |
3 |
0.015
|
|
|
|
proteolysis involved in cellular protein catabolic process
|
GO:0051603 |
147 |
0.015
|
|
|
|
negative regulation of apoptotic signaling pathway
|
GO:2001234 |
104 |
0.015
|
|
|
|
urogenital system development
|
GO:0001655 |
261 |
0.015
|
|
|
|
lateral inhibition
|
GO:0046331 |
1 |
0.015
|
|
|
|
connective tissue development
|
GO:0061448 |
179 |
0.015
|
|
|
|
regulation of sodium ion transport
|
GO:0002028 |
29 |
0.014
|
|
|
|
maintenance of location
|
GO:0051235 |
89 |
0.014
|
|
|
|
cellular response to lipid
|
GO:0071396 |
145 |
0.014
|
|
|
|
regulation of cell size
|
GO:0008361 |
72 |
0.014
|
|
|
|
regulation of mitotic cell cycle
|
GO:0007346 |
126 |
0.014
|
|
|
|
renal inner medulla development
|
GO:0072053 |
3 |
0.014
|
|
|
|
regulation of cellular component size
|
GO:0032535 |
121 |
0.014
|
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.014
|
|
|
|
cellular response to lipopolysaccharide
|
GO:0071222 |
77 |
0.014
|
|
|
|
trabecula formation
|
GO:0060343 |
24 |
0.014
|
|
|
|
angiogenesis
|
GO:0001525 |
201 |
0.014
|
|
|
|
negative regulation of hormone metabolic process
|
GO:0032351 |
4 |
0.014
|
|
|
|
foregut regionalization
|
GO:0060423 |
3 |
0.014
|
|
|
|
mesenchymal cell apoptotic process involved in metanephros development
|
GO:1900200 |
4 |
0.014
|
|
|
|
proteasomal protein catabolic process
|
GO:0010498 |
98 |
0.014
|
|
|
|
cell fate commitment
|
GO:0045165 |
210 |
0.013
|
|
|
|
defense response to bacterium
|
GO:0042742 |
119 |
0.013
|
|
|
|
lipid biosynthetic process
|
GO:0008610 |
179 |
0.013
|
|
|
|
lung development
|
GO:0030324 |
164 |
0.013
|
|
|
|
transmission of nerve impulse
|
GO:0019226 |
76 |
0.013
|
|
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
208 |
0.013
|
|
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
247 |
0.013
|
|
|
|
cellular response to parathyroid hormone stimulus
|
GO:0071374 |
2 |
0.013
|
|
|
|
negative regulation of stem cell maintenance
|
GO:1902455 |
4 |
0.013
|
|
|
|
regulation of protein modification by small protein conjugation or removal
|
GO:1903320 |
57 |
0.013
|
|
|
|
regulation of rna polymerase ii transcriptional preinitiation complex assembly
|
GO:0045898 |
2 |
0.013
|
|
|
|
metal ion homeostasis
|
GO:0055065 |
189 |
0.013
|
|
|
|
negative regulation of androgen biosynthetic process
|
GO:2000180 |
1 |
0.013
|
|
|
|
intracellular mrna localization
|
GO:0008298 |
4 |
0.013
|
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.013
|
|
|
|
ribonucleoside triphosphate catabolic process
|
GO:0009203 |
199 |
0.013
|
|
|
|
cellular response to oxidative stress
|
GO:0034599 |
76 |
0.013
|
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.013
|
|
|
|
somatotropin secreting cell differentiation
|
GO:0060126 |
4 |
0.013
|
|
|
|
response to inorganic substance
|
GO:0010035 |
96 |
0.013
|
|
|
|
hydrogen ion transmembrane transport
|
GO:1902600 |
25 |
0.013
|
|
|
|
cellular ion homeostasis
|
GO:0006873 |
165 |
0.013
|
|
|
|
digestive system development
|
GO:0055123 |
200 |
0.013
|
|
|
|
regulation of alpha beta t cell activation
|
GO:0046634 |
53 |
0.013
|
|
|
|
positive regulation of cellular component biogenesis
|
GO:0044089 |
94 |
0.013
|
|
|
|
cell substrate adhesion
|
GO:0031589 |
130 |
0.012
|
|
|
|
regulation of chemotaxis
|
GO:0050920 |
53 |
0.012
|
|
|
|
germline cell cycle switching mitotic to meiotic cell cycle
|
GO:0051729 |
1 |
0.012
|
|
|
|
cerebellum formation
|
GO:0021588 |
1 |
0.012
|
|
|
|
renal system development
|
GO:0072001 |
225 |
0.012
|
|
|
|
biological phase
|
GO:0044848 |
20 |
0.012
|
|
|
|
negative regulation of protein tyrosine kinase activity
|
GO:0061099 |
3 |
0.012
|
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
220 |
0.012
|
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.012
|
|
|
|
cellular response to organonitrogen compound
|
GO:0071417 |
145 |
0.012
|
|
|
|
regulation of ion transmembrane transport
|
GO:0034765 |
119 |
0.012
|
|
|
|
regulation of rho protein signal transduction
|
GO:0035023 |
71 |
0.012
|
|
|
|
regulation of cytoskeleton organization
|
GO:0051493 |
122 |
0.012
|
|
|
|
planar cell polarity pathway involved in pericardium morphogenesis
|
GO:0061354 |
2 |
0.012
|
|
|
|
microtubule based movement
|
GO:0007018 |
84 |
0.012
|
|
|
|
energy coupled proton transmembrane transport against electrochemical gradient
|
GO:0015988 |
3 |
0.012
|
|
|
|
positive regulation of cilium movement
|
GO:0003353 |
1 |
0.012
|
|
|
|
regulation of protein catabolic process
|
GO:0042176 |
108 |
0.012
|
|
|
|
protein autophosphorylation
|
GO:0046777 |
61 |
0.012
|
|
|
|
regulation of mesenchymal cell apoptotic process involved in metanephros development
|
GO:1900211 |
4 |
0.012
|
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
213 |
0.012
|
|
|
|
regulation of secretion by cell
|
GO:1903530 |
249 |
0.012
|
|
|
|
regulation of cellular response to stress
|
GO:0080135 |
159 |
0.012
|
|
|
|
positive regulation of epithelial cell proliferation involved in lung morphogenesis
|
GO:0060501 |
3 |
0.012
|
|
|
|
regulation of hormone levels
|
GO:0010817 |
211 |
0.012
|
|
|
|
mesonephric duct development
|
GO:0072177 |
5 |
0.012
|
|
|
|
positive regulation of cell motility
|
GO:2000147 |
116 |
0.012
|
|
|
|
purine nucleoside metabolic process
|
GO:0042278 |
241 |
0.011
|
|
|
|
developmental maturation
|
GO:0021700 |
193 |
0.011
|
|
|
|
regulation of cytokine production
|
GO:0001817 |
266 |
0.011
|
|
|
|
actin filament bundle assembly
|
GO:0051017 |
40 |
0.011
|
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
205 |
0.011
|
|
|
|
regulation of reactive oxygen species biosynthetic process
|
GO:1903426 |
2 |
0.011
|
|
|
|
positive regulation of hormone secretion
|
GO:0046887 |
38 |
0.011
|
|
|
|
apical junction assembly
|
GO:0043297 |
15 |
0.011
|
|
|
|
sphingolipid metabolic process
|
GO:0006665 |
45 |
0.011
|
|
|
|
positive regulation of nucleoside metabolic process
|
GO:0045979 |
91 |
0.011
|
|
|
|
wound healing
|
GO:0042060 |
157 |
0.011
|
|
|
|
nuclear division
|
GO:0000280 |
158 |
0.011
|
|
|
|
potassium ion transport
|
GO:0006813 |
52 |
0.011
|
|
|
|
cytokine production
|
GO:0001816 |
319 |
0.011
|
|
|
|
biomineral tissue development
|
GO:0031214 |
64 |
0.011
|
|
|
|
guanosine containing compound catabolic process
|
GO:1901069 |
144 |
0.011
|
|
|
|
regulation of cell migration
|
GO:0030334 |
219 |
0.011
|
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
218 |
0.011
|
|
|
|
regulation of mitotic cell cycle phase transition
|
GO:1901990 |
73 |
0.011
|
|
|
|
peptidyl threonine modification
|
GO:0018210 |
31 |
0.011
|
|
|
|
regulation of stem cell differentiation
|
GO:2000736 |
50 |
0.011
|
|
|
|
negative regulation of hormone biosynthetic process
|
GO:0032353 |
4 |
0.011
|
|
|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
155 |
0.011
|
|
|
|
negative regulation of mesenchymal cell apoptotic process involved in nephron morphogenesis
|
GO:0072040 |
4 |
0.011
|
|
|
|
establishment of endothelial blood brain barrier
|
GO:0014045 |
3 |
0.011
|
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
205 |
0.011
|
|
|
|
second messenger mediated signaling
|
GO:0019932 |
73 |
0.011
|
|
|
|
cop9 signalosome assembly
|
GO:0010387 |
2 |
0.011
|
|
|
|
cellular chemical homeostasis
|
GO:0055082 |
215 |
0.011
|
|
|
|
rna processing
|
GO:0006396 |
105 |
0.010
|
|
|
|
jnk cascade
|
GO:0007254 |
72 |
0.010
|
|
|
|
epithelial tube formation
|
GO:0072175 |
130 |
0.010
|
|
|
|
regulation of cell division
|
GO:0051302 |
76 |
0.010
|
|
|
|
membrane organization
|
GO:0061024 |
245 |
0.010
|
|
|
|
negative regulation of cytokine production
|
GO:0001818 |
84 |
0.010
|
|
|
|
hydrogen transport
|
GO:0006818 |
35 |
0.010
|
|
|
|
carboxylic acid biosynthetic process
|
GO:0046394 |
86 |
0.010
|
|
|
|
sensory perception of taste
|
GO:0050909 |
18 |
0.010
|
|
|
|
positive regulation of stress activated mapk cascade
|
GO:0032874 |
48 |
0.010
|
|
|
|
positive regulation of cell morphogenesis involved in differentiation
|
GO:0010770 |
72 |
0.010
|
|
|
|
cellular metal ion homeostasis
|
GO:0006875 |
151 |
0.010
|
|
|
|
nitrogen compound transport
|
GO:0071705 |
271 |
0.010
|
|
|
|
tube formation
|
GO:0035148 |
140 |
0.010
|
|
|
|
ossification
|
GO:0001503 |
216 |
0.010
|
|
|
|
regulation of steroid metabolic process
|
GO:0019218 |
39 |
0.010
|
|
|
|
planar cell polarity pathway involved in cardiac right atrium morphogenesis
|
GO:0061349 |
2 |
0.010
|
|
|
|
uterus morphogenesis
|
GO:0061038 |
2 |
0.010
|
|
|
|
t cell differentiation
|
GO:0030217 |
174 |
0.010
|
|
|
|
germ line sex determination
|
GO:0018992 |
3 |
0.010
|
|
|
|
non canonical wnt signaling pathway via jnk cascade
|
GO:0038031 |
3 |
0.010
|
|
|
|
placenta development
|
GO:0001890 |
140 |
0.010
|
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
220 |
0.010
|
|
|
|
embryonic placenta development
|
GO:0001892 |
98 |
0.010
|
|
|
|
cilium movement
|
GO:0003341 |
28 |
0.010
|
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.010
|
|
|
|
epithelium migration
|
GO:0090132 |
63 |
0.010
|
|
|
|
regulation of protein complex assembly
|
GO:0043254 |
83 |
0.010
|
|